Skip to main content
OpenTrials

Clinical trial condition

Non-small Cell Lung Carcinoma

Explore clinical trials studying Non-small Cell Lung Carcinoma. Study availability and eligibility vary by location and protocol.

43 public trials 5 recruiting studies
Refine in advanced search Browse all conditions

Non-small Cell Lung Carcinoma trial results

Active, not recruiting

DS8201a and Pembrolizumab in Participants With Locally Advanced/Metastatic Breast or Non-Small Cell Lung Cancer

NCT04042701

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +13 more
Locations
  • Univ. of Cali. San Francisco Medical Center San Francisco, California, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • Cancer Specialists of North Florida (Cbo) Jacksonville, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View all 30 locations
View Trial Details
Completed

Chemotherapy and Radiation Therapy With or Without Metformin Hydrochloride in Treating Patients With Stage III Non-small Cell Lung Cancer

NCT02186847

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, +22 more
Locations
  • Lewis and Faye Manderson Cancer Center Tuscaloosa, Alabama, United States
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
  • Sutter Cancer Centers Radiation Oncology Services-Auburn Auburn, California, United States
  • Sutter Cancer Centers Radiation Oncology Services-Cameron Park Cameron Park, California, United States
View all 223 locations
View Trial Details
Completed

A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors

NCT02009449

Conditions
Adenocarcinoma, Adnexal Diseases, Breast Cancer, +64 more
Locations
  • UCLA Medical Hematology & Oncology Los Angeles, California, United States
  • UCSF San Francisco, California, United States
  • Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
  • Florida Cancer Specialists & Research Institute Sarasota, Florida, United States
View Trial Details
Completed

Study of Capmatinib in Indian Patients With MET Exon 14 Skipping Mutation Positive Advanced NSCLC.

NCT05110196

Conditions
Bronchial Diseases, Bronchial Neoplasms, Carcinoma, +12 more
Locations
  • Novartis Investigative Site Gujarat, India
  • Novartis Investigative Site Mangalore, Karnataka, India
  • Novartis Investigative Site Thalassery, Kerala, India
  • Novartis Investigative Site Trivandrum, Kerala, India
View all 15 locations
View Trial Details
Completed

Neoadjuvant Pembrolizumab

NCT02818920

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Mayo Clinic Rochester, Minnesota, United States
  • Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States
  • Duke University Medical Center Durham, North Carolina, United States
View Trial Details
Completed

A Study to Learn About Lorlatinib in Patients With Non-Small Cell Lung Cancer Which Could Not Be Controlled

NCT06282991

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • CHANG GUNG MEMORIAL HOSPITAL Kaohsiung Branch Kaohsiung City, Taiwan
  • Chung Shan Medical University Hospital Taichung, Taiwan
  • Taichung Veterans General Hospital Taichung, Taiwan
  • National Taiwan University Hospital Taipei, Taiwan
View Trial Details
Completed

Detection of Plasma DNA in Non Small Cell and Small Cell Lung Cancer Patients

NCT00213798

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
Locations
  • Service de Pneumologie, Hôpital Lyautey Strasbourg, France
  • Service de Chirurgie Thoracique, Hôpital Civil Strasbourg, France
  • Service de Pneumologie, Hôpital Civil Strasbourg, France
  • Service de Pneumologie, Hôpital de Hautepierre Strasbourg, France
View Trial Details

Related conditions